Asia

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

See Prices or Subscribe
Asia

Latest Asia Analysis

Industry Trend Analysis - Pharmaceutical Growth Potential Limited By Pricing Controls - SEPT 2014

The government of India's insistence on the low pricing of essential drugs will reduce the country's attractiveness to pharmaceutical firms, as it limits the overall market's growth potential. BMI maintains that the government needs to increase spending on healthcare in order to improve patient access to medical services, which will in turn drive demand for healthcare products.

READ FULL ARTICLE...